Beckman Coulter Life Sciences partners with Flownamics on bioprocess culture monitoring solution

Beckman Coulter Life Sciences, a global leader in laboratory automation and biotechnology innovation, announces a partnership with Flownamics to create an automated, on-line solution for bioprocess culture monitoring and control. This delivers a critical and practical update to the significant unmet need for automated, real-time cell analysis in the current bioprocessing environment.

Image Credit: Beckman Coulter Life Sciences

The agreement unites the company’s Vi-CELL BLU Cell Viability Analyzer with the Seg-Flow S3 Automated On-Line Sampling System from Flownamics to create a seamless user experience.

This is a great combination to create a precise, rapid cell analysis platform for real-time characterization of bioprocess cell cultures. Our mission at Beckman Coulter Life Sciences is to be a trusted partner to help reduce errors, automate workflows, and expedite turnaround time. We’re excited to collaborate with Flownamics to bring this synergy to labs around the world looking for bioprocessing solutions.”

Bhagya Wijayawardena, Product Manager, Vi-CELL BLU Analyzer

Industry trends are moving toward the implementation of automated process analytical technology (PAT) strategies that are designed to bring analytics closer to the operation, eliminate gaps in real-time process monitoring, and develop a deeper understanding of the bioprocess. By integrating the two products into one workflow, a robust, rapid cell analysis PAT platform is now available for real-time cell characterization of bioprocess cell cultures.

This automated integration removes error-prone manual steps while enabling load-and-go sample runs for up to eight bioreactors, GMP compliance with electronic data management, and continuous control of viable cell density, including remote workflows. The duo also helps remove manual sample preparation and sample dilution.

The user-friendly Vi-CELL BLU Cell Viability Analyzer features large sample capacity while fully automating and expediting sample preparation, analysis, and post-run cleaning, with the option to use a 24-position sample carousel or a 96-well plate for sample delivery. Cell viability can be reported in percentage, concentration and cell count, and instrument software features data integrity tools for 21 CFR Part 11 compliance.

As a worldwide leader in autosampling for bioprocess, Flownamics is proud to introduce this new integration of Beckman Coulter Life Sciences’ Vi-CELL BLU analyzer and the Flownamics Seg-Flow S3 Sampling System. This new strategic relationship will provide users with a hands-free, consistent sampling process within a fully automated on-line system.”

Michael Biksacky, President, Flownamics

The Seg-Flow S3 Automated On-Line Sampling System features robust hardware coupled with the intuitive handling of tubing with intelligent pinch valves and non-contact ultrasonic sensors. A series of LED status lights indicate the phases of sampling and the sequence of cleaning. The user interface offers intuitive menus with planning options and reagent status information.

Learn more about the benefits of integration of Seg-Flow S3 Automated On-Line Sampling System and Vi-CELL BLU Cell Viability Analyzer at: https://becls.co/3Ol6qpD.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Beckman Coulter Life Sciences. (2022, August 26). Beckman Coulter Life Sciences partners with Flownamics on bioprocess culture monitoring solution. News-Medical. Retrieved on April 27, 2024 from https://www.news-medical.net/news/20220826/Beckman-Coulter-Life-Sciences-partners-with-Flownamics-on-bioprocess-culture-monitoring-solution.aspx.

  • MLA

    Beckman Coulter Life Sciences. "Beckman Coulter Life Sciences partners with Flownamics on bioprocess culture monitoring solution". News-Medical. 27 April 2024. <https://www.news-medical.net/news/20220826/Beckman-Coulter-Life-Sciences-partners-with-Flownamics-on-bioprocess-culture-monitoring-solution.aspx>.

  • Chicago

    Beckman Coulter Life Sciences. "Beckman Coulter Life Sciences partners with Flownamics on bioprocess culture monitoring solution". News-Medical. https://www.news-medical.net/news/20220826/Beckman-Coulter-Life-Sciences-partners-with-Flownamics-on-bioprocess-culture-monitoring-solution.aspx. (accessed April 27, 2024).

  • Harvard

    Beckman Coulter Life Sciences. 2022. Beckman Coulter Life Sciences partners with Flownamics on bioprocess culture monitoring solution. News-Medical, viewed 27 April 2024, https://www.news-medical.net/news/20220826/Beckman-Coulter-Life-Sciences-partners-with-Flownamics-on-bioprocess-culture-monitoring-solution.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Beckman Coulter Life Sciences presenting at SLAS2023